Shuttle Pharmaceuticals Holdings (SHPH) Other Non-Current Liabilities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $23423.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 76.58% year-over-year to $23423.0 in Q1 2026; TTM through Mar 2026 was $23423.0, a 76.58% decrease from a year earlier, with the FY2025 full-year figure at $99687.0, up 294.32% from the prior year.
• Other Non-Current Liabilities eased to $23423.0 in Q1 2026 per SHPH's latest filing, from $99687.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $1.4 million in Q1 2023 and bottomed at $10965.0 in Q2 2025.
• The 4-year median for Other Non-Current Liabilities is $214615.0 (2024), against an average of $354432.1.
• Biggest YoY gain for Other Non-Current Liabilities was 474.92% in 2025; the steepest drop was 96.96% in 2025.
• Year by year, Other Non-Current Liabilities stood at $414512.0 in 2023, then tumbled by 93.9% to $25281.0 in 2024, then jumped by 294.32% to $99687.0 in 2025, then tumbled by 76.5% to $23423.0 in 2026.
• Per Business Quant, the three latest SHPH Other Non-Current Liabilities figures stand at $23423.0 (Q1 2026), $99687.0 (Q4 2025), and $426054.0 (Q3 2025).